IQV vs MTD
IQVIA and Mettler Toledo, both Healthcare
IQVIA is the larger company at $28B against $23B. On trailing earnings MTD is the cheaper of the two at a P/E of 31.5 against 32.5, a gap that is only a bargain if the two are growing at similar rates. Over the past year IQV returned +47% against +14% for MTD.
| Figure | IQV | MTD |
|---|---|---|
| Last close | $262 | $1398 |
| Market cap | $28B | $23B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 32.5 | 31.5 |
| 1-year return | +47% | +14% |
| 5-year return | +5.6% | -5.1% |
| Ryufin Smart Scoresector-relative, 1–10 | 9/10 | 9/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
IQVIA
Revenue of $4.2B in Q1 2026, net income $274M. Its largest reported line is Research And Development Solutions, 56% of the disclosed total.
Mettler Toledo
Revenue of $1.0B in Q2 2026, net income $233M. Its largest reported line is Us Operations Segment Member, 34% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.